(2017) New therapeutic approach by sirolimus for enteropathy treatment in patients with LRBA deficiency. European Annals of Allergy and Clinical Immunology. pp. 235-239. ISSN 1764-1489
Full text not available from this repository.
Abstract
Purpose. To report the successful use of sirolimus for management of enteropathy in four patients with LPS-responsive beige-like anchor protein (LRBA) deficiency. Methods. Case series. Results. sirolimus therapy led to a complete improvement of symptoms including decrease in frequency and severity of diarrhea, as well as patients' weight gain. No signs of abdominal cramps and anorexia were also detected during the follow up period after treatment. Conclusions. sirolimus with its potential efficacy and immunomodulatory properties may be recommended for the treatment of severe enteropathy refractory to conventional therapy in patients with LRBA deficiency.
Item Type: | Article |
---|---|
Keywords: | sirolimus enteropathy lrba deficiency common variable immune deficiency autoimmunity common variable immunodeficiency inflammatory-bowel-disease x-linked syndrome immune dysregulation autoimmune enteropathy polyendocrinopathy mutations ipex hypogammaglobulinemia management |
Divisions: | Faculty of Medicine > Department of Basic Science > Immunology Department |
Page Range: | pp. 235-239 |
Journal or Publication Title: | European Annals of Allergy and Clinical Immunology |
Journal Index: | ISI |
Volume: | 49 |
Number: | 5 |
Identification Number: | https://doi.org/10.23822/EurAnnACI.1764-1489.22 |
ISSN: | 1764-1489 |
Depositing User: | مهندس مهدی شریفی |
URI: | http://eprints.mui.ac.ir/id/eprint/309 |
Actions (login required)
View Item |